Research highlights urgent need for greater awareness to aid early diagnosis of bone cancers in young people
New research led by experts at the University of Nottingham calls for greater awareness of the symptoms of bone cancers in ...
Medindia16h
New England Journal of Medicine Publishes Results of Global, Multicenter eNRGy Study Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer
New England Journal of Medicine Publishes eNRGy Trial Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer ...
New England Journal Of Medicine Publishes: Efficacy Of Zenocutuzumab In NRG1 Fusion-Positive Cancer
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinic ...
‘Apple Cider Vinegar’: What is Pleomorphic Sarcoma Undifferentiated? All About Milla Blake’s Deadly Cancer Diagnosis on the Netflix Show
The new Netflix show Apple Cider Vinegar dramatizes the shocking true story of Belle Gibson (Kaitlyn Dever), an Australian ...
Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services
Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) and its oncology-focused subsidiary, Citius ...
Le Lézard11h
2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results
Inc. today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS). "We are pleased to see Abecma expansion in the third ...